Adial Pharmaceuticals Receives Notice of Allowance for U.S. Patent Covering Expanded Genotype Combinations Identified Using the Company’s Genetic Diagnostic for Addiction Treatment
October 17, 2024 09:00 ET
|
Adial Pharmaceuticals, Inc
GLEN ALLEN, Va., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies...
Henry J. Carter Specialty Hospital receives Enhanced Respiratory Care Standards of Care Accreditation
October 16, 2024 10:30 ET
|
The Physician-Patient Alliance for Health & Safety
New York, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Henry J. Carter is the first long-term acute care hospital (LTACH) and Skilled Nursing Facility (SNF) in New York City to meet the new standard of...
FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office
October 16, 2024 09:15 ET
|
Fibrobiologics, Inc.
HOUSTON, Oct. 16, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the...
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi
October 15, 2024 08:00 ET
|
HealthLynked Corp
NAPLES, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), a leader in connecting patients, doctors, and healthcare data, announced the filing of its...
BioVie Receives Notice of Allowance for Japan Patent Application Covering Novel Liquid Formulation of Terlipressin
October 15, 2024 08:00 ET
|
BioVie, Inc.
Patents covering BioVie’s terlipressin liquid formulation now secured in the United States, India, Japan and Chile, and are pending in eight additional markets Liquid formulation has demonstrated...
Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease
October 15, 2024 06:00 ET
|
IMPACT BIOMEDICAL INC
HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...
Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform
October 15, 2024 05:00 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology
October 14, 2024 09:45 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Global PROTAC Therapy Market Clinical Trials Drug Approval Insight
October 14, 2024 08:06 ET
|
KuicK Research
Delhi, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Global PROTAC Targeted Protein Degraders Market Opportunity & Clinical Trials Insight 2027 Report Finding & Inclusions: First PROTAC Drug...
VoIP-Pal Voluntarily Withdraws Recently Filed Complaints in Western Texas Against Verizon and T-Mobile to Focus on Stronger Antitrust Path
October 14, 2024 08:00 ET
|
Voip-Pal.Com Inc.
WACO, Texas, Oct. 14, 2024 (GLOBE NEWSWIRE) -- VoIP-Pal.com Inc. (“VoIP-Pal” or the “Company”) (OTCQB: VPLM) announces that it has voluntarily withdrawn its two recently filed federal patent...